Contraception & Metabolic Changes in HIV-positive Women

抗逆转录病毒治疗(Art)的副作用的处理已成为治疗的主要焦点。 人类免疫缺陷病毒(HLV)感染者。这些副作用中最普遍的是 就是代谢并发症。随着越来越多的妇女感染艾滋病毒，以及艾滋病毒/艾滋病成为一种慢性 疾病而不是致命的诊断，这些妇女中更多的人将寻找生孩子和 太空怀孕，而不是终止其生殖能力。然而，尽管在 一般文献指出使用避孕药会导致严重的代谢失调，特别是在某些地区 这与艾滋病毒及其治疗中出现的副作用重叠，目前还没有研究检查是否 避孕激素的使用增加了艾滋病毒感染妇女代谢并发症的风险。一个 妇女机构间艾滋病毒研究(WIHS)队列的二次数据分析被建议作为第一步 对这个问题的调查。培训计划旨在提供信息背景 以及必要的研究经验，使受训人员能够执行研究计划。赞助商将 贡献他们在艾滋病毒/艾滋病、代谢失调和研究方法方面的专业知识。

Management of the side effects of antiretroviral therapy (ART) has become a primary focus in the treatment of human immunodeficiency virus (HlV)-infected individuals. Among the most pervasive of these side effects are the metabolic complications. As more women are infected with HIV, and as HIV/AIDS becomes a chronic disease rather than a lethal diagnosis, more of these women will be looking for ways to have families and space pregnancies, rather than to terminate their ability to reproduce. However, despite research in the general literature that points to significant metabolic dysregulation with contraceptive use, especially in areas that overlap with the side effects seen in HIV and its treatment, no research has yet examined whether or not contraceptive hormone use contributes to HIV-infected women's risk for metabolic complications. A secondary data analysis of the Women's Interagency HIV Study (WIHS) cohort is proposed as an initial step towards investigating this problem. The training plan is designed to provide the informational background and research experience necessary to allow the trainee to carry out the research plan. The sponsors will contribute their expertise in HIV/AIDS, metabolic dysregulation, and research methodology.